Unlocking the Molecular Mechanisms of DNA Repair and Platinum Drug Resistance in Cancer Chemotherapy

Publisher： Bentham Science Publishers

E-ISSN： 2212-3903|4|1|19-28

ISSN： 1574-8855

Source： Current Drug Therapy, Vol.4, Iss.1, 2009-01, pp. : 19-28

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New Cancer Chemotherapy Agents: Inhibitors of DNA Polymerase

By  

Current Drug Therapy, Vol. 3, Iss. 1, 2008-01 ,pp. : 44-53

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Epigenetics in Drug Resistance in Cancer

By  

Epigenetic Diagnosis & Therapy, Vol. 1, Iss. 2, 2016-03 ,pp. : 106-119

Bentham Science Publishers

Access to resources Recommend Favorite

Bevacizumab Plus Platinum-Based Chemotherapy: In Advanced Non-Small Cell Lung Cancer

By Wagstaff Antona J.   Keam Susan J.   McCormack Paul L.  

BioDrugs, Vol. 23, Iss. 3, 2009-06 ,pp. : 187-196

Adis International

Access to resources Recommend Favorite

Who's Winning the War? Molecular Mechanisms of Antibiotic Resistance in Helicobacter pylori

By  

Current Drug Therapy, Vol. 3, Iss. 3, 2008-09 ,pp. : 190-203

Bentham Science Publishers

Access to resources Recommend Favorite

The Association of Radiotherapy and Chemotherapy: Esophageal Cancer

By  

Current Drug Therapy, Vol. 5, Iss. 3, 2010-08 ,pp. : 172-179

Bentham Science Publishers

Access to resources Recommend Favorite